Healthcare utilization by patients with diabetes and diabetic retinopathy among national health insurance enrollees in Taiwan

Taiwan Journal of Public Health

Volumn 27, Issue 2, 2008, Pages 101-109

  Tsa, Ming Tsu ^a,b   Woung, Lin Chung ^a,c   Tsa, Wei Her ^b   Tsai, Ching Yao ^a,d   Chou, Hsin Kai ^a,e   Lin, Cheng Heng ^d   Chou, Pesus ^d  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF BUSINESS   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Diabetic retinopathy; Health expenditure

Indexed keywords

EID: 47149107075     PISSN: 10232141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimate, and projections. Diabetes Care 1998;21:1414-31.
2. Centers for Disease Control and Prevention. Diabetes Public Health Resource. Statistics: Diabetes Surveillance, 1999.
3. Chinese source
4. Logminiene Z, Norkus A, Valius L. Direct and indirect diabetes costs in the world. Medicina 2004;40:16-26.
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source
9. Bloomgarden ZT. The epidemiology of complications. Diabetes Care 2002;255:924-32.
10. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 1999;159:1450-6.
11. Chinese source
12. Wilensky GR. Framing the public policy questions: financial incentives for efficiency and effectiveness. Med Care Res Rev 2004;61:31s-6s.
13. Savolainen EA, Lee QP. Diabetic retinopathy-need and demand for photocoagulation and its cost-effectiveness: evaluation based on services in the United Kingdom. Diabetologia 1982;23:138-40.
14. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics. Ophthalmology 1989;96:255-64.
15. Tai TY, Yang CL, Chang CJ, et al. Epidemiology of diabetes mellitus among adults in Taiwan, R.O.C. J Med Assoc Thai 1987;70:42-8.
16. Chou P, Liao MJ, Kuo HS, Hsiao KJ, Tsai ST. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994;17:1055-8.
17. Chinese source
18. Charlson RJ, Lovelock JE, Andreae MO, Warren SG. Oceanic phytoplankton, atmospheric sulphur, cloud albedo and climate. Nature 1987;326:655-61.
19. Klein R, Klein BEK, Moss SE. Davis MD. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
20. Dowse GK, Humphrey AR, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998;147:448-57.
21. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
22. Lantion-Ang LC. Epidemiology of diabetes mellitus in Western Pacific region: focus on Philippines. Diabetes Res Clin Pract 2000;50:S29-34.
23. Mitchell P, Smith W, Wanh JJ, Attebo K. Prevalence of diabetic retinopathy in an older community. The blue mountains eye study. Ophthalmology 1998;105:406-11.
24. Wang WQ, Ip TP, Lam KSL. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Res Clin Pract 1998;39:185-91.
25. Chen MS. Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ. Prevalence and risk factors of diabetic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol 1992;114:723-30.
26. Chinese source
27. Wandell PE, Tovi J. The quality of life of elderly diabetic patients. J Diabetes Complicat 2000;14:25-30.
28. Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol 2008;246:151-9.
29. Krop JS, Powe NR, Weiler WE, Shaffer TJ, Saudek CD, Anderson GF. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care. Diabetes Care 1998;21:747-52.
30. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754-60.